Show simple item record

dc.contributor.authorCroaker, Andrew
dc.contributor.authorKing, Graham J
dc.contributor.authorPyne, John H
dc.contributor.authorAnoopkumar-Dukie, Shailendra
dc.contributor.authorSimanek, Vilim
dc.contributor.authorLiu, Lei
dc.date.accessioned2021-09-23T06:39:36Z
dc.date.available2021-09-23T06:39:36Z
dc.date.issued2017
dc.identifier.issn1383-5742
dc.identifier.doi10.1016/j.mrrev.2017.09.001
dc.identifier.urihttp://hdl.handle.net/10072/408304
dc.description.abstractBlack salves are escharotic skin cancer therapies in clinical use since the mid 19th century. Sanguinaria canadensis, a major ingredient of black salve formulations, contains a number of bioactive phytochemicals including the alkaloid sanguinarine. Despite its prolonged history of clinical use, conflicting experimental results have prevented the carcinogenic potential of sanguinarine from being definitively determined. Sanguinarine has a molecular structure similar to known polyaromatic hydrocarbon carcinogens and is a DNA intercalator. Sanguinarine also generates oxidative and endoplasmic reticulum stress resulting in the unfolded protein response and the formation of 8-hydroxyguanine genetic lesions. Sanguinarine has been the subject of contradictory in vitro and in vivo genotoxicity and murine carcinogenesis test results that have delayed its carcinogenic classification. Despite this, epidemiological studies have linked mouthwash that contains sanguinarine with the development of oral leukoplakia. Sanguinarine is also proposed as an aetiological agent in gallbladder carcinoma. This literature review investigates the carcinogenic potential of sanguinarine. Reasons for contradictory genotoxicity and carcinogenesis results are explored, knowledge gaps identified and a strategy for determining the carcinogenic potential of sanguinarine especialy relating to black salve are discussed. As patients continue to apply black salve, especially to skin regions suffering from field cancerization and skin malignancies, an understanding of the genotoxic and carcinogenic potential of sanguinarine is of urgent clinical relevance.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherElsevier
dc.publisher.placeNetherlands
dc.relation.ispartofpagefrom46
dc.relation.ispartofpageto56
dc.relation.ispartofjournalMutation Research: Reviews
dc.relation.ispartofvolume774
dc.subject.fieldofresearchGenetics
dc.subject.fieldofresearchOncology and carcinogenesis not elsewhere classified
dc.subject.fieldofresearchcode3105
dc.subject.fieldofresearchcode321199
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsBiotechnology & Applied Microbiology
dc.subject.keywordsGenetics & Heredity
dc.subject.keywordsToxicology
dc.titleCarcinogenic potential of sanguinarine, a phytochemical used in 'therapeutic' black salve and mouthwash
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationCroaker, A; King, GJ; Pyne, JH; Anoopkumar-Dukie, S; Simanek, V; Liu, L, Carcinogenic potential of sanguinarine, a phytochemical used in 'therapeutic' black salve and mouthwash, Mutation Research: Reviews, 2017, 774, pp. 46-56
dcterms.dateAccepted2017-09-02
dc.date.updated2021-09-23T06:38:24Z
gro.hasfulltextNo Full Text
gro.griffith.authorAnoopkumar-Dukie, Shailendra


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record